0001033409-11-000003.txt : 20110519
0001033409-11-000003.hdr.sgml : 20110519
20110519152931
ACCESSION NUMBER: 0001033409-11-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110407
FILED AS OF DATE: 20110519
DATE AS OF CHANGE: 20110519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ESHELMAN FREDRIC N
CENTRAL INDEX KEY: 0001033409
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27570
FILM NUMBER: 11857764
MAIL ADDRESS:
STREET 1: PPD INC
STREET 2: 929 NORTH FRONT STREET
CITY: WILMINGTON
STATE: NC
ZIP: 28401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC
CENTRAL INDEX KEY: 0001003124
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 561640186
STATE OF INCORPORATION: NC
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 929 NORTH FRONT STREET
CITY: WILMINGTON
STATE: NC
ZIP: 28401
BUSINESS PHONE: 9102510081
MAIL ADDRESS:
STREET 1: 929 NORTH FRONT STREET
CITY: WILMINGTON
STATE: NC
ZIP: 28401
4
1
edgar.xml
PRIMARY DOCUMENT
X0303
4
2011-04-07
0001003124
PHARMACEUTICAL PRODUCT DEVELOPMENT INC
PPDI
0001033409
ESHELMAN FREDRIC N
929 NORTH FRONT STREET
WILMINGTON
NC
28401
1
1
0
0
Executive Chairman
Common Stock
2011-04-07
5
G
0
83000
0
D
6969741
D
Common Stock
409500
I
GRAT
Common Stock
11258
I
LLC
Common Stock
1685
I
Spouse
Stock Options (to buy)
27.27
2012-02-23
2021-02-23
Common Stock
90000
90000
D
Restricted Stock Units
Common Stock
30000
30000
D
Stock Options (to buy)
20.45
2011-02-25
2020-02-25
Common Stock
103506
103506
D
Stock Options (to buy)
25.74
2010-02-18
2019-02-18
Common Stock
103506
103506
D
Stock Options (to buy)
19.94
2009-11-20
2018-11-20
Common Stock
51753
51753
D
Stock Options (to buy)
43.26
2009-02-20
2018-02-20
Common Stock
103506
103506
D
Stock Options (to buy)
32.47
2008-02-21
2017-02-20
Common Stock
51753
51753
D
Stock Options (to buy)
33.44
2007-02-22
2016-02-21
Common Stock
207012
207012
D
Stock Options (to buy)
20.47
2005-11-16
2014-11-15
Common Stock
258764
258764
D
Stock Options (to buy)
14.78
2006-12-03
2013-12-02
Common Stock
124207
124207
D
Stock Options (to buy)
14.44
2005-12-03
2012-12-02
Common Stock
41403
41403
D
Direct Holdings include an anti-dilution adjustment of 1,870 shares to restricted stock held made in connection with the June 14, 2010 spin-off of Furiex Pharmaceuticals, Inc.
The options vest in equal increments of 1/3 each on 2/23/12, 2/23/13 and 2/23/14.
Each restricted stock unit (RSU) represents a contingent right to receive one share of PPDI common stock. These RSUs vest in three equal installments on 2/23/12, 2/23/13 and 2/23/14. Unvested RSUs are forfeited at termination of employment.
The options vest in equal increments of 1/3 each on 2/25/11, 2/25/12 and 2/25/13.
The options were awarded on 2/18/09 and vest in three equal increments on 2/18/10, 2/18/11 and 2/18/12.
The options were awarded on 11/20/08 and vest as follows: 16,666 on 11/20/09, 16,667 on 11/20/10 and 16,667 on 11/20/11.
The options were awarded on 2/20/08 and vest in three equal increments on 2/20/09, 2/20/10 and 2/20/11.
The options were awarded on 2/20/07 and vest as follows: 16,666 on 2/21/08, 16,667 on 2/21/09 and 16,667 on 2/21/10.
The options were awarded on 2/22/06 and vest in three equal increments on 2/22/07, 2/22/08 and 2/22/09.
The options were awarded on 11/16/04 and vest in four equal increments on 11/16/05, 11/16/06, 11/16/07 and 11/16/08.
Lisa C. Noecker attorney-in-fact for Fred N. Eshelman
2011-05-19